Latest Biotech News

Preclinical studies identified actionable routes to reverse resistance to platinum chemotherapy: targeting FBXL5 sensitized iron-rich colorectal tumors to oxaliplatin via ferroptosis mechanisms,...

Two laboratory advances aim to improve preclinical translation: a 3D-printed scaffold model refined glioblastoma drug screening to better mimic tumor microenvironments, and a Cell paper showed...

Novartis moved to acquire Avidity Biosciences in a roughly $12 billion deal, adding a trio of late-stage RNA-based programs targeting Duchenne muscular dystrophy, myotonic dystrophy type 1 and...

GSK struck a pact worth up to $357 million with French biotech Syndivia for a preclinical prostate cancer antibody-drug conjugate (ADC). The agreement, disclosed after a European cancer conference...

Novo Nordisk walked away from earlier acquisition talks for Akero Therapeutics before returning to complete a $4.7 billion purchase of MASH drug developer Akero, according to reporting on the deal...

Flagship Pioneering launched Expedition Medicines, an AI-driven startup that claims to learn chemical rules to bind small molecules to historically 'undruggable' protein targets. The company...

Town Hall Ventures closed a $440 million fund to back startups deploying AI to improve healthcare access and outcomes for underserved populations. The fund, the firm’s fourth, signals growing...

Biotech-focused exchange-traded funds have posted double-digit gains over the past six months, with XBI up roughly 34%, IBB up ~25% and ARKG surging about 42% in the recent stretch. Analysts...

Walgreens and other community pharmacies are positioning themselves as strategic partners for biopharma to improve specialty medication adherence and patient support, driven by rising advanced...

Researchers compared four exome capture platforms using the DNBSEQ high-throughput sequencer to benchmark coverage, on-target rates and variant-calling performance. The study provides sequencing...

Industry reports promoted agile clinical site networks as a way to accelerate oncology trials by aligning sponsors, trial sites and investigators on common operational goals. The piece advised...

Researchers developed 3D-printed scaffold models to improve glioblastoma drug screening, enabling more physiologically relevant tumor architectures than traditional 2D cultures. The platform,...

Novartis announced its agreement to acquire Avidity Biosciences for roughly $12 billion in cash, a deal that hands Novartis a portfolio of RNA-based candidates targeting neuromuscular diseases....

Flagship Pioneering launched Expedition Medicines, a startup using artificial intelligence to map the chemistry of small‑molecule binding against proteins historically deemed undruggable....

Town Hall Ventures closed a $440 million fund to back startups applying artificial intelligence to expand healthcare access and outcomes for underserved populations. The firm positioned the fourth...

A recent study found that long‑acting injectable formulations of buprenorphine reduce the need for inpatient services among patients with opioid use disorder, shifting care from hospitals to...

Researchers demonstrated that rotavirus RNA levels detected in wastewater correlate with population‑level infection rates and vaccination coverage across the United States. The study used...

A team led by Zhou et al. used metagenomic sequencing to identify strain‑level diversity among bacterial pathogens causing pneumonia, improving resolution beyond species identification. The study...

A multicenter consortium validated artificial‑intelligence models for classifying urothelial neoplasms on digital pathology slides, reporting robust performance across institutions. The research...

Recent reviews and studies synthesize advances in CAR‑T and CAR‑NK cell therapies for acute myeloid leukemia (AML), outlining engineered strategies to overcome antigen heterogeneity and myeloid...